First Trust Advisors LP Pacira Bio Sciences, Inc. Transaction History

First Trust Advisors LP

$108 Billion
Q1 2025

A detailed history of First Trust Advisors LP transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 49,192 shares of PCRX stock, worth $1.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

49,192

Holding current value

$1.11 Million

% of portfolio

0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$18.33 - $27.25 $901,689 - $1.34 Million	49,192 New	49,192 $1.22 Million
Q3 2024 Nov 13, 2024	BUY	$11.7 - $28.46 $349,280 - $849,616	29,853 Added 38.0%	108,408 $1.63 Million
Q2 2024 Aug 13, 2024	BUY	$25.5 - $31.51 $1.12 Million - $1.38 Million	43,848 Added 126.34%	78,555 $2.25 Million
Q1 2024 May 13, 2024	SELL	$27.7 - $35.48 $319,602 - $409,368	-11,538 Reduced 24.95%	34,707 $1.01 Million
Q4 2023 Feb 13, 2024	BUY	$26.32 - $34.31 $1.22 Million - $1.59 Million	46,245 New	46,245 $1.56 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $488,703 - $642,675	13,530 New	13,530 $542,000
Q4 2022 Feb 09, 2023	SELL	$38.19 - $57.45 $741,420 - $1.12 Million	-19,414 Reduced 34.73%	36,491 $1.41 Million
Q3 2022 Nov 14, 2022	SELL	$51.24 - $58.89 $790,735 - $908,790	-15,432 Reduced 21.63%	55,905 $2.97 Million
Q2 2022 Aug 12, 2022	BUY	$51.49 - $81.64 $1.88 Million - $2.98 Million	36,469 Added 104.59%	71,337 $4.16 Million
Q1 2022 May 13, 2022	BUY	$60.03 - $76.49 $1.25 Million - $1.59 Million	20,791 Added 147.69%	34,868 $2.66 Million
Q4 2021 Feb 08, 2022	BUY	$47.97 - $62.21 $410,191 - $531,957	8,551 Added 154.74%	14,077 $847,000
Q3 2021 Nov 15, 2021	SELL	$54.64 - $61.3 $1.26 Million - $1.41 Million	-23,010 Reduced 80.63%	5,526 $310,000
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $532,975 - $630,329	9,006 Added 46.11%	28,536 $1.73 Million
Q1 2021 May 14, 2021	SELL	$59.31 - $78.82 $1.46 Million - $1.94 Million	-24,613 Reduced 55.76%	19,530 $1.37 Million
Q4 2020 Feb 02, 2021	SELL	$50.47 - $66.26 $302,517 - $397,162	-5,994 Reduced 11.96%	44,143 $2.64 Million
Q3 2020 Nov 05, 2020	BUY	$51.97 - $63.0 $165,108 - $200,151	3,177 Added 6.77%	50,137 $3.01 Million
Q2 2020 Jul 22, 2020	BUY	$30.8 - $52.47 $417,340 - $710,968	13,550 Added 40.56%	46,960 $2.46 Million
Q1 2020 May 06, 2020	BUY	$28.4 - $50.7 $113,969 - $203,459	4,013 Added 13.65%	33,410 $1.12 Million
Q4 2019 Feb 03, 2020	SELL	$36.31 - $46.83 $1.23 Million - $1.58 Million	-33,769 Reduced 53.46%	29,397 $1.33 Million
Q3 2019 Nov 04, 2019	BUY	$35.66 - $44.99 $1.78 Million - $2.24 Million	49,780 Added 371.88%	63,166 $2.41 Million
Q2 2019 Jul 30, 2019	SELL	$36.57 - $47.97 $2.03 Million - $2.66 Million	-55,501 Reduced 80.57%	13,386 $582,000
Q1 2019 May 09, 2019	SELL	$36.47 - $42.17 $428,777 - $495,792	-11,757 Reduced 14.58%	68,887 $2.62 Million
Q4 2018 Feb 07, 2019	BUY	$41.31 - $52.16 $3.33 Million - $4.21 Million	80,644 New	80,644 $3.47 Million
Q2 2018 Aug 02, 2018	SELL	$27.5 - $39.8 $515,157 - $745,573	-18,733 Closed	0 $0
Q1 2018 Apr 23, 2018	BUY	$29.98 - $46.35 $561,615 - $868,274	18,733 New	18,733 $584,000

Others Institutions Holding PCRX

# of Institutions

256

Shares Held

50.9M

Call Options Held

157K

Put Options Held

139K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.03B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Pacira Bio Sciences, Inc. Transaction History